The epithelium as a target of glucocorticoid action in the treatment of asthma.
Schwiebert
L M
LM
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland 21224, USA.
Stellato
C
C
Schleimer
R P
RP
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000188:drug therapy / Q000503:physiopathology; D016207:Cytokines / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D012137:Respiratory System / Q000187:drug effects* / Q000503:physiopathology; D013256:Steroids
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D005938:Glucocorticoids; D018836:Inflammation Mediators; D011956:Receptors, Cell Surface; D011965:Receptors, Glucocorticoid; D013256:Steroids